Gufic BioSciences Share Price

NSE
GUFICBIO •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Gufic BioSciences
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
38.59% Gain from 52W Low
-4.7
TTM PE Ratio
Below industry Median
47.1
Price to Book Ratio
High in industry
6.7
Dividend yield 1yr %
0.03
TTM PEG Ratio
PEG TTM is much higher than 1
2

Gufic BioSciences Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Gufic BioSciences Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
207.79 Cr
204.18 Cr
202.81 Cr
194.99 Cr
201.78 Cr

Gufic BioSciences Yearly Revenue

Mar 2024
808.84 Cr

Gufic BioSciences Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
19.31 Cr
21.77 Cr
20.86 Cr
20.05 Cr
22.26 Cr

Gufic BioSciences Yearly Net Profit/Loss

Mar 2024
86.14 Cr
Gufic BioSciences Result Highlights
  • Gufic BioSciences Ltd reported a 2.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 3.7%.

  • Its expenses for the quarter were up by 4.8% QoQ and 6.2% YoY.

  • The net profit decreased 11.3% QoQ and decreased 13.3% YoY.

  • The earnings per share (EPS) of Gufic BioSciences Ltd stood at 1.9 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Gufic BioSciences shareholding Pattern

Promoter
72.5%
Foreign Institutions
0.3%
Mutual Funds
2.9%
Domestic Institutions
3%
Public
24.2%
Promoter
72.5%
Foreign Institutions
0.2%
Mutual Funds
2.5%
Domestic Institutions
2.5%
Public
24.8%
Promoter
72.5%
Foreign Institutions
0.2%
Mutual Funds
2.3%
Domestic Institutions
2.4%
Public
24.9%
Promoter
72.5%
Foreign Institutions
0.1%
Mutual Funds
2.1%
Domestic Institutions
2.2%
Public
25.2%
Promoter
72.5%
Foreign Institutions
0.5%
Mutual Funds
1.6%
Domestic Institutions
1.7%
Public
25.3%
Promoter
75%
Foreign Institutions
0.7%
Mutual Funds
1.5%
Domestic Institutions
1.7%
Public
22.6%

Gufic BioSciences Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
392.20
10Day EMA
399.50
12Day EMA
402.20
20Day EMA
411.10
26Day EMA
416.10
50Day EMA
425.50
100Day EMA
422.30
200Day EMA
398.90
5Day SMA
394.50
10Day SMA
398.30
20Day SMA
413.40
30Day SMA
424.90
50Day SMA
437.00
100Day SMA
432.80
150Day SMA
414.60
200Day SMA
396.90
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
90039 Rs
112967 Rs
Week Rs
38093 Rs
63973 Rs
Month Rs
31087 Rs
62871 Rs
Resistance & Support
383.37
Pivot
Resistance
First Resistance
388.63
Second Resistance
392.47
Third Resistance
397.73
Support
First Support
379.53
Second support
374.27
Third Support
370.43
Relative Strength Index
32.89
Money Flow Index
15.38
MACD
-13.91
MACD Signal
-11.67
Average True Range
20.74
Average Directional Index
42.98
Rate of Change (21)
-9.62
Rate of Change (125)
-3.58

Gufic BioSciences Company background

Founded in: 1984
Managing director: Jayesh P Choksi
Gufic Biosciences (GBL) was incorporated in Jul84. The Company is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 4042 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a longstanding presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil.In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a sellers market. The company plan to invest further in RD activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.In 202021, Gufic Lifesciences Private Limited amalgamated with the Company through the Scheme of Amalgamation which became effective from May 21, 2021. GUFIC UK LIMITED (GUL), a wholly owned subsidiary of the Company, was incorporated in United Kingdom on March 15, 2022. Similarly, in 2023, Gufic Ireland Limited (GIL) was incorporated on March 02, 2023.
Read More

Gufic BioSciences FAQs

Gufic BioSciences share price is ₹384.8 in NSE and ₹383.55 in BSE as on 20/2/2025 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

Gufic BioSciences share price in the past 1-year return was 21.19. The Gufic BioSciences share hit a 1-year low of Rs. 277.65 and a 1-year high of Rs. 504.25.

The market cap of Gufic BioSciences is Rs. 3858.68 Cr. as of 20/2/2025 12:00:00 AM.

The PE ratios of Gufic BioSciences is 46.89 as of 20/2/2025 12:00:00 AM.

The PB ratios of Gufic BioSciences is 6.69 as of 20/2/2025 12:00:00 AM

The Mutual Fund Shareholding in Gufic BioSciences was 2.92% at the end of 20/2/2025 12:00:00 AM.

You can easily buy Gufic BioSciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -